CompletedNot Applicable

Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)

Egypt100 participantsStarted 2006-02

Plain-language summary

Mini abstract : Altogether 100 patients with 117 episodes of ASBO were randomized into control and gastrografin groups. Eight episodes in eight patients were excluded. Gastrografin group showed a significant decrease of both the time between admission and operation and that of hospital stay .The need for surgery was reduced but statistically insignificant.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to our surgical department by postoperative SBO were considered for inclusion in this trial. Exclusion Criteria: * Age less than 18 years * Large bowel obstruction * Recent (within 4 weeks) abdominal surgery * Ileus * Cancer peritonitis * Peritonitis * Strangulation symptoms and signs * Obstructed abdominal wall or groin hernia * Subtotal or total colectomy * All patients in whom the final diagnosis was not SBO

What they're measuring

resolving

Timeframe: 48 hours

Trial details

NCT IDNCT00738855

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-01

View on ClinicalTrials.gov More Small Bowel Obstruction trials